CalciMedica, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CalciMedica, Inc. (CALC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 17.32 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 5.56K shares, a 78.69% decline year-over-year.
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 11.76K shares, a 15.32% decline year-over-year.
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 937.00 shares.
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 15.00K shares.
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 55.94K shares, a 75.52% decline from fiscal 2024.
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 228.47K shares, a 136.53% increase from fiscal 2023.
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 96.59K shares, a 85.48% decline from fiscal 2022.
- CalciMedica, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 665.13K shares, a 142.13% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 5.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 17.32K shares 10-Q · filed 2026-08-11 | 18.26K shares derived: sum of 3 quarters · filed 2026-08-11 | 33.26K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 11.76K shares 10-Q · filed 2026-05-12 | 12.70K shares derived: sum of 2 quarters · filed 2026-05-12 | 27.70K shares derived: sum of 3 quarters · filed 2026-05-12 | 53.81K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 937.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 15.94K shares derived: sum of 2 quarters · filed 2026-03-03 | 42.05K shares derived: sum of 3 quarters · filed 2026-03-03 | 55.94K shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 41.11K shares derived: sum of 2 quarters · filed 2025-11-12 | 55.00K shares 10-Q · filed 2025-11-12 | 55.00K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 26.11K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 40.00K shares 10-Q · filed 2025-08-12 | 40.00K shares derived: sum of 3 quarters · filed 2025-08-12 | 40.00K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 13.89K shares 10-Q · filed 2025-05-14 | 13.89K shares derived: sum of 2 quarters · filed 2025-05-14 | 13.89K shares derived: sum of 3 quarters · filed 2025-05-14 | 19.06K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-27 | 5.17K shares derived: sum of 3 quarters · filed 2025-03-27 | 228.47K shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 5.17K shares derived: sum of 2 quarters · filed 2024-11-13 | 228.47K shares 10-Q · filed 2024-11-13 | 228.95K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 5.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 228.47K shares 10-Q · filed 2024-08-12 | 228.95K shares derived: sum of 3 quarters · filed 2024-08-12 | 228.95K shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 223.31K shares 10-Q · filed 2024-05-13 | 223.78K shares derived: sum of 2 quarters · filed 2024-05-13 | 223.78K shares derived: sum of 3 quarters · filed 2024-05-13 | |
| 2023-12-31 | 477.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 477.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 96.59K shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 96.12K shares 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | 96.12K shares 10-Q · filed 2023-08-11 | |||
| 2022-12-31 | 665.13K shares 10-K · filed 2023-03-09 | |||
| 2021-12-31 | 274.70K shares 10-K · filed 2022-03-11 | |||
| 2020-12-31 | 406.41K shares 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |